| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000045 | Autophagosome assembly | Increases phenotype | PMID:30726812; PMID:32619457 |
| GO:0000080 | Mitotic g1 phase | Decreases phenotype | PMID:32497684; PMID:33411230 |
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:30020114; PMID:33411230 |
| GO:0000085 | Mitotic g2 phase | Affects phenotype | PMID:35678645 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Increases phenotype | PMID:30020114; PMID:32087850; PMID:32497684 |
| GO:0000132 | Establishment of mitotic spindle orientation | Decreases phenotype | PMID:29126329 |
| GO:0000281 | Mitotic cytokinesis | Affects phenotype | PMID:39454710 |
| GO:0000729 | Dna double-strand break processing | Increases phenotype | PMID:36399157 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:34027802; PMID:37390851; PMID:37515497; PMID:38382706 |
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:35993611 |
| GO:0001837 | Epithelial to mesenchymal transition | Increases phenotype | PMID:31778776 |
| GO:0002244 | Hematopoietic progenitor cell differentiation | Increases phenotype | PMID:31059917 |
| GO:0002523 | Leukocyte migration involved in inflammatory response | Increases phenotype | PMID:34027802; PMID:34998820; PMID:35378083; PMID:37373040 |
| GO:0003720 | Telomerase activity | Decreases phenotype | PMID:35151814 |
| GO:0003958 | Nadph-hemoprotein reductase activity | Increases phenotype | PMID:34472326 |
| GO:0003993 | Acid phosphatase activity | Decreases phenotype | PMID:30520250 |
| GO:0004035 | Alkaline phosphatase activity | Affects phenotype | PMID:35437857; PMID:35777681 |
| GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity | Increases phenotype | PMID:31730885; PMID:33393179 |
| GO:0004129 | Cytochrome-c oxidase activity | Affects phenotype | PMID:15207643; PMID:30165701 |
| GO:0004364 | Glutathione transferase activity | Affects phenotype | PMID:12641979; PMID:25374376; PMID:25632966; PMID:25632966; PMID:26546711; PMID:29019276; PMID:26546711; PMID:27206700; PMID:29019276; PMID:30520250; PMID:31004597; PMID:31702096; PMID:33411230; PMID:35437857 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:18057710; PMID:18057710; PMID:29019276; PMID:31702096; PMID:27206700; PMID:29019276; PMID:31702096 |
| GO:0004497 | Monooxygenase activity | Increases phenotype | PMID:26466350 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:16858674; PMID:18057710; PMID:18057710; PMID:26546711; PMID:29019276; PMID:22052664; PMID:26546711; PMID:29019276; PMID:31702096; PMID:33663268; PMID:35437857 |
| GO:0004784 | Superoxide dismutase activity | Affects phenotype | PMID:16858674; PMID:18057710; PMID:18057710; PMID:25632966; PMID:26546711; PMID:29019276; PMID:25632966; PMID:25946486; PMID:26546711; PMID:29019276; PMID:31004597; PMID:31702096; PMID:31830554; PMID:32417428; PMID:33663268; PMID:35437857; PMID:35777681; PMID:38278498 |
| GO:0004855 | Xanthine oxidase activity | Increases phenotype | PMID:27206700 |
| GO:0005243 | Gap junction channel activity | Decreases phenotype | PMID:31568845 |
| GO:0005776 | Autophagosome | Increases phenotype | PMID:39454710 |
| GO:0005975 | Carbohydrate metabolic process | Affects phenotype | PMID:36736873 |
| GO:0006006 | Glucose metabolic process | Affects phenotype | PMID:36736873 |
| GO:0006054 | N-acetylneuraminate metabolic process | Affects phenotype | PMID:35437857 |
| GO:0006059 | Hexitol metabolic process | Affects phenotype | PMID:36736873 |
| GO:0006121 | Mitochondrial electron transport, succinate to ubiquinone | Increases phenotype | PMID:15207643 |
| GO:0006123 | Mitochondrial electron transport, cytochrome c to oxygen | Decreases phenotype | PMID:30165701 |
| GO:0006259 | Dna metabolic process | Increases phenotype | PMID:25781201 |
| GO:0006260 | Dna replication | Decreases phenotype | PMID:28461126 |
| GO:0006264 | Mitochondrial dna replication | Affects phenotype | PMID:32619457 |
| GO:0006289 | Nucleotide-excision repair | Increases phenotype | PMID:28238931 |
| GO:0006304 | Dna modification | Increases phenotype | PMID:26238291; PMID:26377693; PMID:28457874; PMID:30714215; PMID:34529316 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:35151814 |
| GO:0006497 | Protein lipidation | Increases phenotype | PMID:32619457 |
| GO:0006506 | Gpi anchor biosynthetic process | Decreases phenotype | PMID:27931811 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:36736873 |
| GO:0006534 | Cysteine metabolic process | Affects phenotype | PMID:36736873 |
| GO:0006580 | Ethanolamine metabolic process | Affects phenotype | PMID:36736873 |
| GO:0006582 | Melanin metabolic process | Affects phenotype | PMID:34856342 |
| GO:0006606 | Protein import into nucleus | Affects phenotype | PMID:32062438 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:31830554; PMID:32417428; PMID:36736873; PMID:39111554 |
| GO:0006633 | Fatty acid biosynthetic process | Affects phenotype | PMID:27329536 |
| GO:0006635 | Fatty acid beta-oxidation | Affects phenotype | PMID:24107266 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:31730885; PMID:32417428; PMID:39111554 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:36736873 |
| GO:0006703 | Estrogen biosynthetic process | Affects phenotype | PMID:31730885 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:25170436; PMID:27206700; PMID:27206700; PMID:35437857; PMID:36736873; PMID:28032951; PMID:28032951; PMID:29019276; PMID:29019276; PMID:29526570; PMID:31568845; PMID:32061149; PMID:33663268; PMID:34856342; PMID:35437857; PMID:35437857; PMID:36736873; PMID:38278498 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:18057710; PMID:18057710; PMID:26546711; PMID:22052664; PMID:26546711; PMID:28238931; PMID:28412278; PMID:31004597; PMID:31702096 |
| GO:0006783 | Heme biosynthetic process | Increases phenotype | PMID:31059917 |
| GO:0006805 | Xenobiotic metabolic process | Increases phenotype | PMID:26091049 |
| GO:0006809 | Nitric oxide biosynthetic process | Increases phenotype | PMID:24685774; PMID:26086121; PMID:31004597 |
| GO:0006914 | Autophagy | Increases phenotype | PMID:39454710 |
| GO:0006915 | Apoptotic process | Affects phenotype | PMID:23510837; PMID:23994263; PMID:24239969; PMID:24246761; PMID:24246761; PMID:26086121; PMID:24954032; PMID:26086121; PMID:26359795; PMID:26419736; PMID:28412278; PMID:28681665; PMID:30776357; PMID:32619457; PMID:32802178; PMID:34529316; PMID:35567930; PMID:35777681; PMID:36193556 |
| GO:0006919 | Activation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:27208085 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:28681665; PMID:28681665; PMID:32061149; PMID:33393179; PMID:29019276; PMID:31059917; PMID:32061149; PMID:33393179; PMID:37364758 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:10693172; PMID:10693172; PMID:28428138; PMID:28882572; PMID:29218508; PMID:29549414; PMID:31542801; PMID:16242274; PMID:16970932; PMID:23333640; PMID:24657529; PMID:26856715; PMID:27195522; PMID:27448386; PMID:27448386; PMID:28111842; PMID:28111842; PMID:28111842; PMID:30776357; PMID:28428138; PMID:28461126; PMID:28882572; PMID:29170806; PMID:29218508; PMID:29218508; PMID:33249052; PMID:29545172; PMID:29549414; PMID:30776357; PMID:30842367; PMID:31542801; PMID:32062438; PMID:33393179; PMID:33411230; PMID:34762139; PMID:34998820 |
| GO:0006979 | Response to oxidative stress | Increases phenotype | PMID:15621696; PMID:15969944 |
| GO:0007005 | Mitochondrion organization | Decreases phenotype | PMID:32619457 |
| GO:0007009 | Plasma membrane organization | Decreases phenotype | PMID:30726812 |
| GO:0007049 | Cell cycle | Increases phenotype | PMID:16406622 |
| GO:0007059 | Chromosome segregation | Increases phenotype | PMID:27913846 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:25242404; PMID:26657896; PMID:31568845 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:31568845; PMID:38278498 |
| GO:0007346 | Regulation of mitotic cell cycle | Affects phenotype | PMID:28681665 |
| GO:0007566 | Embryo implantation | Decreases phenotype | PMID:39454710 |
| GO:0007601 | Visual perception | Decreases phenotype | PMID:31730894 |
| GO:0007611 | Learning or memory | Decreases phenotype | PMID:30085273; PMID:31730894 |
| GO:0007612 | Learning | Decreases phenotype | PMID:26420751; PMID:32255272; PMID:32619457; PMID:32619457 |
| GO:0007613 | Memory | Decreases phenotype | PMID:32255272; PMID:32619457; PMID:32619457; PMID:34979192 |
| GO:0008080 | N-acetyltransferase activity | Increases phenotype | PMID:30439556 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:33939976 |
| GO:0008202 | Steroid metabolic process | Affects phenotype | PMID:36736873 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:30664314; PMID:31730885 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:32417428; PMID:39111554 |
| GO:0008210 | Estrogen metabolic process | Affects phenotype | PMID:34929288 |
| GO:0008219 | Cell death | Increases phenotype | PMID:24664296; PMID:25946486; PMID:29502740; PMID:33411230; PMID:35777681; PMID:35993611 |
| GO:0008253 | 5'-nucleotidase activity | Increases phenotype | PMID:31702096 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:23994263; PMID:24289642; PMID:24847786; PMID:29746904; PMID:25230394; PMID:26359795; PMID:28533128; PMID:30236600; PMID:32802178; PMID:33429317; PMID:34998820; PMID:35678645 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:24464499; PMID:25820237; PMID:26657896; PMID:27740625; PMID:27901495; PMID:35870112; PMID:37972769 |
| GO:0008285 | Negative regulation of cell population proliferation | Affects phenotype | PMID:28049045; PMID:29524502; PMID:29526570; PMID:30385349; PMID:30659931; PMID:34979192 |
| GO:0008306 | Associative learning | Decreases phenotype | PMID:34979192 |
| GO:0008344 | Adult locomotory behavior | Decreases phenotype | PMID:16858674 |
| GO:0008360 | Regulation of cell shape | Affects phenotype | PMID:33429317 |
| GO:0008610 | Lipid biosynthetic process | Affects phenotype | PMID:26303333; PMID:27544633 |
| GO:0010189 | Vitamin e biosynthetic process | Decreases phenotype | PMID:18057710; PMID:18057710; PMID:26546711; PMID:26546711 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Decreases phenotype | PMID:27901495; PMID:30085273 |
| GO:0010467 | Gene expression | Affects phenotype | PMID:28233961 |
| GO:0010669 | Epithelial structure maintenance | Decreases phenotype | PMID:31255691 |
| GO:0010719 | Negative regulation of epithelial to mesenchymal transition | Increases phenotype | PMID:30659931 |
| GO:0010820 | Positive regulation of t cell chemotaxis | Increases phenotype | PMID:30453624 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:29126329 |
| GO:0010923 | Negative regulation of phosphatase activity | Affects phenotype | PMID:30520250 |
| GO:0010976 | Positive regulation of neuron projection development | Decreases phenotype | PMID:28049045 |
| GO:0014902 | Myotube differentiation | Decreases phenotype | PMID:24431215 |
| GO:0014904 | Myotube cell development | Decreases phenotype | PMID:35567930 |
| GO:0015020 | Glucuronosyltransferase activity | Increases phenotype | PMID:30439556 |
| GO:0015746 | Citrate transport | Increases phenotype | PMID:26303333 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:16858674; PMID:18057710; PMID:18057710; PMID:25632966; PMID:26546711; PMID:30776357; PMID:25632966; PMID:26546711; PMID:29019276; PMID:30776357; PMID:31702096; PMID:32061149; PMID:35437857 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:24847786; PMID:25724548; PMID:27003318; PMID:30236600 |
| GO:0016712 | Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | Increases phenotype | PMID:34999049; PMID:35437857 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:25374376; PMID:30520250; PMID:30520250; PMID:30776357; PMID:30776357; PMID:35437857 |
| GO:0019321 | Pentose metabolic process | Affects phenotype | PMID:36736873 |
| GO:0019530 | Taurine metabolic process | Affects phenotype | PMID:36736873 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:36736873 |
| GO:0019825 | Oxygen binding | Increases phenotype | PMID:25632966 |
| GO:0019853 | L-ascorbic acid biosynthetic process | Decreases phenotype | PMID:18057710; PMID:18057710; PMID:26546711; PMID:26546711 |
| GO:0019857 | 5-methylcytosine metabolic process | Affects phenotype | PMID:39967322 |
| GO:0019859 | Thymine metabolic process | Affects phenotype | PMID:36736873 |
| GO:0019860 | Uracil metabolic process | Affects phenotype | PMID:36736873 |
| GO:0022904 | Respiratory electron transport chain | Increases phenotype | PMID:15207643 |
| GO:0030185 | Nitric oxide transport | Increases phenotype | PMID:30726812 |
| GO:0030282 | Bone mineralization | Affects phenotype | PMID:35777681 |
| GO:0030335 | Positive regulation of cell migration | Increases phenotype | PMID:23333640; PMID:30294794; PMID:35870112; PMID:38602648 |
| GO:0030513 | Positive regulation of bmp signaling pathway | Increases phenotype | PMID:27740625 |
| GO:0031589 | Cell-substrate adhesion | Decreases phenotype | PMID:32670863 |
| GO:0031987 | Locomotion involved in locomotory behavior | Decreases phenotype | PMID:32619457 |
| GO:0032125 | Micronucleus organization | Increases phenotype | PMID:29502740; PMID:30842367; PMID:31051210; PMID:32087850; PMID:31515600; PMID:31733235; PMID:32497684; PMID:33961948; PMID:34762139; PMID:35882637 |
| GO:0032148 | Activation of protein kinase b activity | Decreases phenotype | PMID:30659931; PMID:34283317 |
| GO:0032205 | Negative regulation of telomere maintenance | Increases phenotype | PMID:37579952 |
| GO:0032464 | Positive regulation of protein homooligomerization | Increases phenotype | PMID:34332006 |
| GO:0032502 | Developmental process | Affects phenotype | PMID:39967322 |
| GO:0032649 | Regulation of type ii interferon production | Affects phenotype | PMID:22562770 |
| GO:0032930 | Positive regulation of superoxide anion generation | Increases phenotype | PMID:29524502; PMID:35993611 |
| GO:0033023 | Mast cell homeostasis | Affects phenotype | PMID:34999049 |
| GO:0033090 | Positive regulation of extrathymic t cell differentiation | Increases phenotype | PMID:30664314 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:26022396 |
| GO:0033522 | Histone h2a ubiquitination | Increases phenotype | PMID:23712474 |
| GO:0034101 | Erythrocyte homeostasis | Affects phenotype | PMID:35437857 |
| GO:0034113 | Heterotypic cell-cell adhesion | Increases phenotype | PMID:31748929 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:25242404; PMID:28032951; PMID:28032951; PMID:30520250; PMID:30520250; PMID:31004597; PMID:31568845; PMID:33663268; PMID:38278498; PMID:39111554 |
| GO:0034660 | Ncrna metabolic process | Affects phenotype | PMID:24084393 |
| GO:0036065 | Fucosylation | Decreases phenotype | PMID:33429317 |
| GO:0036123 | Histone h3-k9 dimethylation | Increases phenotype | PMID:32062438 |
| GO:0036269 | Swimming behavior | Decreases phenotype | PMID:34979192 |
| GO:0040015 | Negative regulation of multicellular organism growth | Increases phenotype | PMID:34979192 |
| GO:0042127 | Regulation of cell population proliferation | Affects phenotype | PMID:30664314 |
| GO:0042332 | Gravitaxis | Affects phenotype | PMID:39967322 |
| GO:0042416 | Dopamine biosynthetic process | Decreases phenotype | PMID:26466350 |
| GO:0042421 | Norepinephrine biosynthetic process | Increases phenotype | PMID:26466350 |
| GO:0042431 | Indole metabolic process | Affects phenotype | PMID:36736873 |
| GO:0042448 | Progesterone metabolic process | Affects phenotype | PMID:34929288 |
| GO:0042554 | Superoxide anion generation | Increases phenotype | PMID:28533128 |
| GO:0042593 | Glucose homeostasis | Affects phenotype | PMID:30520250; PMID:37019984 |
| GO:0042634 | Regulation of hair cycle | Affects phenotype | PMID:39967322 |
| GO:0042640 | Anagen | Affects phenotype | PMID:39967322 |
| GO:0043005 | Neuron projection | Decreases phenotype | PMID:37364758 |
| GO:0043030 | Regulation of macrophage activation | Affects phenotype | PMID:35378083 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:28032951; PMID:28032951; PMID:30520250; PMID:29524502; PMID:30385349; PMID:30520250; PMID:30659931; PMID:31368503; PMID:31568845; PMID:34979192; PMID:37579952; PMID:39423996 |
| GO:0043066 | Negative regulation of apoptotic process | Increases phenotype | PMID:35870112 |
| GO:0043280 | Positive regulation of cysteine-type endopeptidase activity involved in apoptotic process | Increases phenotype | PMID:31368503 |
| GO:0043433 | Negative regulation of dna-binding transcription factor activity | Increases phenotype | PMID:26022396 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:36754249 |
| GO:0044237 | Cellular metabolic process | Decreases phenotype | PMID:30020114; PMID:31154059; PMID:31154059; PMID:35151814; PMID:31733235; PMID:31830554; PMID:31830554; PMID:35151814; PMID:32087850; PMID:33393179; PMID:33411230; PMID:34856342; PMID:34929288; PMID:35151814; PMID:35777681; PMID:36941454; PMID:36982514; PMID:37364758; PMID:38382706 |
| GO:0044242 | Cellular lipid catabolic process | Increases phenotype | PMID:24657529; PMID:25374376 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:29746904; PMID:31778776 |
| GO:0044648 | Histone h3-k4 dimethylation | Decreases phenotype | PMID:26149760 |
| GO:0044691 | Tooth eruption | Affects phenotype | PMID:39967322 |
| GO:0045023 | G0 to g1 transition | Affects phenotype | PMID:30020114 |
| GO:0045026 | Plasma membrane fusion | Increases phenotype | PMID:24361490 |
| GO:0045540 | Regulation of cholesterol biosynthetic process | Affects phenotype | PMID:31368503 |
| GO:0045657 | Positive regulation of monocyte differentiation | Increases phenotype | PMID:29524502 |
| GO:0045662 | Negative regulation of myoblast differentiation | Increases phenotype | PMID:35427736 |
| GO:0045666 | Positive regulation of neuron differentiation | Decreases phenotype | PMID:28049045 |
| GO:0045687 | Positive regulation of glial cell differentiation | Decreases phenotype | PMID:28049045 |
| GO:0045732 | Positive regulation of protein catabolic process | Affects phenotype | PMID:35427736 |
| GO:0045793 | Positive regulation of cell size | Decreases phenotype | PMID:28049045 |
| GO:0045919 | Positive regulation of cytolysis | Increases phenotype | PMID:34979192 |
| GO:0045930 | Negative regulation of mitotic cell cycle | Increases phenotype | PMID:23994263; PMID:26148868; PMID:26657896; PMID:27286660; PMID:32087850; PMID:33411230 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Decreases phenotype | PMID:26091049 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:32619457 |
| GO:0046110 | Xanthine metabolic process | Affects phenotype | PMID:36736873 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:36736873 |
| GO:0046466 | Membrane lipid catabolic process | Increases phenotype | PMID:15621696; PMID:27206700; PMID:35920545; PMID:35920545; PMID:36193556; PMID:35993611; PMID:36193556 |
| GO:0046483 | Heterocycle metabolic process | Affects phenotype | PMID:36736873 |
| GO:0046697 | Decidualization | Decreases phenotype | PMID:39454710 |
| GO:0047823 | D-glutamyltransferase activity | Increases phenotype | PMID:34999049 |
| GO:0048866 | Stem cell fate specification | Increases phenotype | PMID:32062438 |
| GO:0050729 | Positive regulation of inflammatory response | Increases phenotype | PMID:36592837 |
| GO:0050847 | Progesterone receptor signaling pathway | Decreases phenotype | PMID:26022396 |
| GO:0050900 | Leukocyte migration | Decreases phenotype | PMID:23539630 |
| GO:0051091 | Positive regulation of dna-binding transcription factor activity | Increases phenotype | PMID:26022396 |
| GO:0051131 | Chaperone-mediated protein complex assembly | Decreases phenotype | PMID:35427736 |
| GO:0051347 | Positive regulation of transferase activity | Increases phenotype | PMID:30520250 |
| GO:0051402 | Neuron apoptotic process | Increases phenotype | PMID:32115946 |
| GO:0051726 | Regulation of cell cycle | Increases phenotype | PMID:24664296 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:26086121; PMID:32619457 |
| GO:0051985 | Negative regulation of chromosome segregation | Increases phenotype | PMID:29126329 |
| GO:0060013 | Righting reflex | Affects phenotype | PMID:39967322 |
| GO:0060291 | Long-term synaptic potentiation | Decreases phenotype | PMID:32255272 |
| GO:0060326 | Cell chemotaxis | Increases phenotype | PMID:31778776 |
| GO:0060346 | Bone trabecula formation | Affects phenotype | PMID:35777681 |
| GO:0060348 | Bone development | Affects phenotype | PMID:35777681 |
| GO:0060395 | Smad protein signal transduction | Increases phenotype | PMID:27740625 |
| GO:0060560 | Developmental growth involved in morphogenesis | Decreases phenotype | PMID:30659931 |
| GO:0060612 | Adipose tissue development | Increases phenotype | PMID:3891103 |
| GO:0060997 | Dendritic spine morphogenesis | Decreases phenotype | PMID:39967322 |
| GO:0061024 | Membrane organization | Decreases phenotype | PMID:30248327 |
| GO:0061370 | Testosterone biosynthetic process | Affects phenotype | PMID:38278498 |
| GO:0061450 | Trophoblast cell migration | Decreases phenotype | PMID:26359795 |
| GO:0061564 | Axon development | Increases phenotype | PMID:37373040 |
| GO:0061902 | Negative regulation of 1-phosphatidylinositol-3-kinase activity | Increases phenotype | PMID:34283317 |
| GO:0070265 | Necrotic cell death | Increases phenotype | PMID:29019276; PMID:37364758 |
| GO:0070266 | Necroptotic process | Increases phenotype | PMID:35777681 |
| GO:0070269 | Pyroptosis | Increases phenotype | PMID:30726812 |
| GO:0070328 | Triglyceride homeostasis | Affects phenotype | PMID:37019984 |
| GO:0070509 | Calcium ion import | Increases phenotype | PMID:30248327 |
| GO:0070633 | Transepithelial transport | Decreases phenotype | PMID:31255691 |
| GO:0070661 | Leukocyte proliferation | Decreases phenotype | PMID:38278498 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:23720242; PMID:34027802; PMID:35777681; PMID:36736873 |
| GO:0071407 | Cellular response to organic cyclic compound | Increases phenotype | PMID:26022396 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:24685774; PMID:25680693; PMID:25724548; PMID:32619457; PMID:33421718; PMID:33421718; PMID:37515497; PMID:34856342; PMID:35437857; PMID:35567930; PMID:35777681; PMID:37515497; PMID:39111554 |
| GO:0080009 | Mrna methylation | Increases phenotype | PMID:37972769 |
| GO:0090090 | Negative regulation of canonical wnt signaling pathway | Increases phenotype | PMID:34283317 |
| GO:0090119 | Vesicle-mediated cholesterol transport | Affects phenotype | PMID:31368503 |
| GO:0090200 | Positive regulation of release of cytochrome c from mitochondria | Increases phenotype | PMID:31568845; PMID:35993611 |
| GO:0090240 | Positive regulation of histone h4 acetylation | Decreases phenotype | PMID:26149760 |
| GO:0090327 | Negative regulation of locomotion involved in locomotory behavior | Increases phenotype | PMID:34979192 |
| GO:0090524 | Cytochrome-b5 reductase activity, acting on nadh | Increases phenotype | PMID:35437857 |
| GO:0097237 | Cellular response to toxic substance | Increases phenotype | PMID:29502735 |
| GO:0097484 | Dendrite extension | Decreases phenotype | PMID:39967322 |
| GO:0097722 | Sperm motility | Decreases phenotype | PMID:37579952 |
| GO:0098508 | Endothelial to hematopoietic transition | Increases phenotype | PMID:31404653 |
| GO:0098532 | Histone h3-k27 trimethylation | Decreases phenotype | PMID:30157460 |
| GO:0098743 | Cell aggregation | Increases phenotype | PMID:27740625 |
| GO:0120252 | Hydrocarbon metabolic process | Affects phenotype | PMID:36736873 |
| GO:0140042 | Lipid droplet formation | Affects phenotype | PMID:31730885; PMID:35993611; PMID:39111554 |
| GO:0140059 | Dendrite arborization | Decreases phenotype | PMID:39967322 |
| GO:0140454 | Protein aggregate center assembly | Increases phenotype | PMID:36941454 |
| GO:0140639 | Positive regulation of pyroptosis | Increases phenotype | PMID:36592837 |
| GO:0160024 | Leydig cell proliferation | Affects phenotype | PMID:38278498 |
| GO:1900119 | Positive regulation of execution phase of apoptosis | Increases phenotype | PMID:29526570 |
| GO:1900181 | Negative regulation of protein localization to nucleus | Increases phenotype | PMID:34283317 |
| GO:1900225 | Regulation of nlrp3 inflammasome complex assembly | Affects phenotype | PMID:34999049 |
| GO:1900409 | Positive regulation of cellular response to oxidative stress | Increases phenotype | PMID:35993611 |
| GO:1900745 | Positive regulation of p38mapk cascade | Increases phenotype | PMID:25233930 |
| GO:1901216 | Positive regulation of neuron death | Increases phenotype | PMID:34332006 |
| GO:1901318 | Negative regulation of flagellated sperm motility | Increases phenotype | PMID:31568845 |
| GO:1901522 | Positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus | Increases phenotype | PMID:26022396 |
| GO:1901525 | Negative regulation of mitophagy | Increases phenotype | PMID:39147092 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:27206700; PMID:29526570; PMID:31568845 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Affects phenotype | PMID:25242404; PMID:28032951; PMID:30520250 |
| GO:1901687 | Glutathione derivative biosynthetic process | Decreases phenotype | PMID:28032951 |
| GO:1901858 | Regulation of mitochondrial dna metabolic process | Affects phenotype | PMID:29145655 |
| GO:1902034 | Negative regulation of hematopoietic stem cell proliferation | Increases phenotype | PMID:32553695 |
| GO:1902108 | Regulation of mitochondrial membrane permeability involved in apoptotic process | Affects phenotype | PMID:35993611 |
| GO:1902552 | Negative regulation of catalase activity | Increases phenotype | PMID:27206700 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:29502740; PMID:30020114; PMID:32497684; PMID:35678645; PMID:39454710 |
| GO:1903165 | Response to polycyclic arene | Increases phenotype | PMID:27589885 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:27206700; PMID:31568845 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Affects phenotype | PMID:28032951; PMID:30520250 |
| GO:1903408 | Positive regulation of p-type sodium:potassium-exchanging transporter activity | Decreases phenotype | PMID:25242404 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:28533128; PMID:30236600; PMID:31830554 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:29526570; PMID:31568845; PMID:32890658; PMID:39423996 |
| GO:1903430 | Negative regulation of cell maturation | Increases phenotype | PMID:34437932 |
| GO:1903543 | Positive regulation of exosomal secretion | Increases phenotype | PMID:31368503 |
| GO:1903561 | Extracellular vesicle | Increases phenotype | PMID:34044057 |
| GO:1903612 | Positive regulation of calcium-dependent atpase activity | Decreases phenotype | PMID:25242404 |
| GO:1903753 | Negative regulation of p38mapk cascade | Decreases phenotype | PMID:35427736 |
| GO:1903980 | Positive regulation of microglial cell activation | Increases phenotype | PMID:34332006 |
| GO:1904613 | Cellular response to 2,3,7,8-tetrachlorodibenzodioxine | Increases phenotype | PMID:26022396 |
| GO:1905376 | Negative regulation of cytochrome-c oxidase activity | Increases phenotype | PMID:30165701 |
| GO:1990349 | Gap junction-mediated intercellular transport | Decreases phenotype | PMID:34283317 |
| GO:1990440 | Positive regulation of transcription from rna polymerase ii promoter in response to endoplasmic reticulum stress | Increases phenotype | PMID:26022396 |
| GO:2000183 | Negative regulation of progesterone biosynthetic process | Increases phenotype | PMID:39423996 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:31568845; PMID:39423996 |
| GO:2000379 | Positive regulation of reactive oxygen species metabolic process | Increases phenotype | PMID:24664296 |
| GO:2000391 | Positive regulation of neutrophil extravasation | Increases phenotype | PMID:37267060 |
| GO:2000409 | Positive regulation of t cell extravasation | Increases phenotype | PMID:30453624 |
| GO:2000421 | Positive regulation of eosinophil extravasation | Increases phenotype | PMID:37267060 |
| GO:2000648 | Positive regulation of stem cell proliferation | Increases phenotype | PMID:34437932 |
| GO:2000786 | Positive regulation of autophagosome assembly | Increases phenotype | PMID:37579952 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:31568845 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:39423996 |
| GO:2000868 | Negative regulation of estrone secretion | Increases phenotype | PMID:39423996 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.